Scinovex
review Open AccessTop 1% cited

Statins for the primary prevention of cardiovascular disease

Cochrane Database of Systematic Reviews · 2013 · Vol. 2021(9) · pp. CD004816–CD004816
Fiona TaylorMark D. HuffmanAna Filipa MacedoTheresa HM MooreMargaret BurkeGeorge Davey SmithKirsten WardShah EbrahimHawkins Gay

Abstract

Reductions in all-cause mortality, major vascular events and revascularisations were found with no excess of adverse events among people without evidence of CVD treated with statins.

Lipoproteins and Cardiovascular HealthHealth Systems, Economic Evaluations, Quality of LifePharmaceutical Practices and Patient OutcomesMedicineCochrane LibraryDiseaseStroke (engine)PlaceboMEDLINEStatinMeta-analysisClinical trialRandomized controlled trial

MeSH terms

AdultCardiovascular DiseasesCause of DeathHumansCholesterol, HDLCholesterol, LDLMyocardial RevascularizationPrimary PreventionRandomized Controlled Trials as TopicHydroxymethylglutaryl-CoA Reductase InhibitorsStroke
Citations
1,829
FWCI
227.21
field-weighted impact
References
427
Percentile
100%
vs. same field & year
Citations per year
References
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Statins for the primary prevention of cardiovascular disease · Scinovex